訊息原文

1 人回報4 年前
After a thorough process of research & rigorous
clinical trials, along with standard of care, at
multiple AIIMS & other Government medical
institutions, into the efficacy of @SriSriTattva's
NAOQ19 formulation, @moayush has approved
NAOQ19 for mild to moderate COVID-19
therapy.
Sri Sri
NAOQ19
ANTIVIRAL &
ANTI-INFLAMMATORY
Dosage: 2 tablets twice/thrice a day
after food or as directed by the physician
60
TABS
500 mg

現有回應

目前尚無回應

增加新回應

  • 撰寫回應
  • 無相關回應
  • 搜尋